Conexeu Sciences Inc. (NASDAQ:CNXU) Short Interest Update

Conexeu Sciences Inc. (NASDAQ:CNXU) was the recipient of a large increase in short interest in the month of May. As of May 29th, there was short interest totaling 21,639 shares, an increase of ∞ from the May 14th total of 0 shares. Based on an average daily volume of 31,620 shares, the short-interest ratio is presently 0.7 days. Approximately 0.1% of the shares of the stock are short sold.

Conexeu Sciences Price Performance

NASDAQ:CNXU traded down $0.84 during trading hours on Friday, hitting $11.29. The stock had a trading volume of 58,391 shares, compared to its average volume of 93,790. Conexeu Sciences has a one year low of $10.87 and a one year high of $18.79.

Analysts Set New Price Targets

Separately, Wall Street Zen raised shares of Conexeu Sciences to a “hold” rating in a report on Saturday, May 30th.

About Conexeu Sciences

Conexeu is a company focused on building a new class of collagen-based regenerative tissue products. The Company was incorporated on November 2, 2022 under the Business Corporations Act (British Columbia) and was continued out of British Columbia and domesticated into the State of Nevada under the laws of the State of Nevada on April 10, 2025. — Conexeu is an early-stage medical device company formed to acquire and commercialize intellectual property (“IP”) developed over more than a decade at the University of British Columbia (the “University”) and the BC Professional Firefighters Burn and Wound Healing Laboratory.